[…]
Read More… from Recent Trends in Hospital Drug Spending and Manufacturer Shortages
This tag is created dynamically through created issue pages
The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer […]
Read More… from FAH Leader Expresses Opposition to Ruling that Overturns 340B Medicare Regulation